UnknownNot Applicable

Effect of Hyoscine- Bromide on Duration of the First Stage of Labor

Egypt60 participantsStarted 2023-09-27

Plain-language summary

Spasmolytic drugs are frequently used in delivery rooms to overcome cervical spasms and thus reduce the duration of labor. The aim of this randomized double blind placebo controlled trial is to study the efficacy of hyoscine butylbromide (HBB) for shortening of the first stage of labor in primigravid women.

Who can participate

Age range20 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Primigravid women.
✓. Singleton pregnancy.
✓. Presenting by the vertex.
✓. Gestational age between 37 and 42 weeks
✓. In active phase of labor with a cervical dilatation between 4-5 cm, with either intact membranes or spontaneous rupture of membranes for less than 12 h

Exclusion criteria

✕. Previous uterine scarring.
✕. Malpresentation.
✕. Antepartum hemorrhage.
✕. Labor induction
✕. Contraindication to vaginal delivery.
✕. Contraindication to hyoscine.

What they're measuring

duration of first stage of labor

Timeframe: 6 months

Trial details

NCT IDNCT06056869

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-04

Contact for this trial

Maii Nawara, MD

+201001848388 maii_nawara@hotmail.com

View on ClinicalTrials.gov More Labor trials